Catalyst Pharmaceuticals (CPRX) Revenue Growth (1y) (2019 - 2026)
Catalyst Pharmaceuticals (CPRX) Revenue Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | - |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | 64.03% |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 96.43% |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 5.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.63% |
| Dec 31, 2025 | 7.61% |
| Sep 30, 2025 | 15.31% |
| Jun 30, 2025 | 19.44% |
| Mar 31, 2025 | 43.56% |
| Dec 31, 2024 | 28.26% |
| Sep 30, 2024 | 25.33% |
| Jun 30, 2024 | 23.23% |
| Mar 31, 2024 | 15.40% |
| Dec 31, 2023 | 81.98% |
| Sep 30, 2023 | 79.39% |
| Jun 30, 2023 | 87.49% |
| Mar 31, 2023 | 98.12% |
| Dec 31, 2022 | 58.60% |
| Sep 30, 2022 | 59.21% |
| Jun 30, 2022 | 46.06% |
| Mar 31, 2022 | 42.66% |
| Dec 31, 2021 | 23.52% |
| Sep 30, 2021 | 22.64% |
| Jun 30, 2021 | 22.83% |